Cough, Cold and Allergy (Hay Fever) Remedies in China

Sales of cough and cold remedies have gradually been normalising in China in 2024, although from a high base established in 2023 during the wave of COVID-19 infections. Persistent respiratory illnesses throughout late 2023 and early 2024 have sustained demand to some extent. However, sales in the summer have underperformed compared with 2023, due to a combination of waning post-COVID-19 demand, and changes in distribution channels.

The Cough, Cold and Allergy (Hay Fever) Remedies in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.